Privia CFO sells 8,385 shares after option exercise
Privia Health Group EVP & CFO David Mountcastle reported an exercise-and-sale of company stock.
Rhea-AI Filing Summary
Privia Health Group EVP & CFO David Mountcastle reported an exercise-and-sale of company stock. On May 1 and May 4, 2026, he exercised a total of 8,385 stock options for common shares at an exercise price of $2.00 per share and sold the same 8,385 shares in open-market transactions around $25 per share, according to the Form 4.
The sales were executed under a previously adopted Rule 10b5-1 trading plan, indicating they were pre-planned. After these transactions, Mountcastle directly owns 214,847 common shares and has indirect ownership of 8,695 shares held by his spouse, reflecting that he retains a substantial equity stake in Privia Health Group.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 8,385 shares ($193K approx. pre-tax spread)
Exercise and Sale
13 txns
Insider
Mountcastle David
Role
EVP & Chief Financial Officer
Sold
8,385 shs ($210K)
Approx. gross sale proceeds
$210K
Approx. exercise cost
$17K
Approx. pre-tax spread
$193K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 202 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Purchase) | 52 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Purchase) | 592 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Purchase) | 360 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 1,206 | $2.00 | $2K |
| Sale | Common Stock, par value $0.01 per share | 1,206 | $25.00 | $30K |
| Exercise | Stock Option (Right to Purchase) | 1,297 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Purchase) | 541 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Purchase) | 3,010 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Purchase) | 2,331 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 7,179 | $2.00 | $14K |
| Sale | Common Stock, par value $0.01 per share | 7,179 | $25.03 | $180K |
| holding | Common Stock, $0.01 par value per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 17,196 contracts (Direct);
Common Stock, par value $0.01 per share — 214,847 shares (Direct);
Common Stock, $0.01 par value per share — 8,695 shares (Indirect, By spouse)
Footnotes (3)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. All of the stock options are fully vested and exercisable.
Key Figures
Shares sold: 8,385 shares
Sale prices: $25.00–$25.20 per share
Option exercise price: $2.00 per share
+4 more
7 metrics
Shares sold
8,385 shares
Total common shares sold in open-market transactions on May 1 and 4, 2026
Sale prices
$25.00–$25.20 per share
Weighted average price range for reported sales, including $25.03 per share
Option exercise price
$2.00 per share
Exercise price for 8,385 options converted into common stock
Direct holdings after trades
214,847 shares
Common shares directly owned by the CFO following the transactions
Indirect holdings
8,695 shares
Common shares held indirectly through spouse as of May 1, 2026
Options exercised
8,385 options
Total options exercised (exerciseShares) per transaction summary
Rule 10b5-1 plan
Pre-planned trades
Footnote confirms sales executed under a previously adopted Rule 10b5-1 plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, stock options, derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"All of the stock options are fully vested and exercisable."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Privia Health Group (PRVA) CFO David Mountcastle report?
He reported exercising 8,385 stock options at $2.00 per share and selling 8,385 common shares in open-market trades around $25 per share on May 1 and May 4, 2026, as shown in the Form 4 filing.
At what price did the Privia Health (PRVA) CFO exercise his stock options?
He exercised stock options for 8,385 underlying common shares at an exercise price of $2.00 per share. These exercises converted option awards into common stock, which was then sold in the market shortly thereafter, according to the Form 4 data.
Were the Privia Health Group (PRVA) CFO’s stock sales pre-planned under Rule 10b5-1?
Yes. A footnote states the transaction was carried out under a Rule 10b5-1 trading plan previously adopted by David Mountcastle. Such plans pre-schedule trades, indicating the timing was arranged in advance rather than decided opportunistically.
What information did the Form 4 give about the CFO’s remaining stock options at Privia Health (PRVA)?
The Form 4 shows several stock option grants with remaining balances, including grants with exercise prices of $2.00 and expiration dates extending to 2030. Footnotes state all reported stock options are fully vested and exercisable at the time of these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
